A2 Biotherapeutics, Inc. logo

A2 Biotherapeutics, Inc.

Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells.

138 employees · est. 2018 · Agoura Hills, United States

VS
Tmunity Therapeutics logo

Tmunity Therapeutics

Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse array of diseases.

12 employees · est. 2015

Tmunity Therapeutics is the older company (2018 vs 2015); A2 Biotherapeutics, Inc. is the larger of the two.

Side-by-Side Comparison

A2 Biotherapeutics, Inc. Tmunity Therapeutics
Founded
2018 2015 older
Headquarters
Agoura Hills, United States Not tracked yet
Employees
138 larger 12
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Series B Acquired
Total Funding
$190.50M $220.00M
Funding Rounds
4 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
T Cell Therapy, Solid Tumors, Cancer Research, Immunotherapy, Oncology, Cell Therapy Development, Targeted Therapy, Genetic Engineering, Investor-backed, Early-stage Biotechnology, Southern California Biotech, Advanced Targeting Technology, Drug Development, Clinical Research Immunotherapy, T Cell Engineering, T Cell Receptor (TCR), Regulatory T Cells (Treg), Universal Engineered T Cells, Genetically Engineered T Cells, Oncology, Infectious Diseases, Autoimmune Disorders, Clinical Trials, Cell And Gene Therapy, Peripheral Blood T Cells, Cord Blood T Cells, Tumor Derived T Cells, Multi-center Clinical Studies
Website
a2bio.com tmunity.com
A2 Biotherapeutics, Inc. logo

About A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc. is a biotechnology startup that aims to revolutionize cancer treatment with its powerful and precise T cell therapy. The company's slogan, "Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells," encapsulates its mission to push the boundarie...

Tmunity Therapeutics logo

About Tmunity Therapeutics

Tmunity Therapeutics, founded in 2015, is at the forefront of biotech innovation, striving to reshape the landscape of immunotherapy through its pioneering work in T cell engineering. The company emphasizes T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered...

We will tell you when either one moves

BounceWatch watches A2 Biotherapeutics, Inc. and Tmunity Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at A2 Biotherapeutics, In... and Tmunity Therapeutics — by email.

Frequently Asked Questions

A2 Biotherapeutics, Inc. — Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells.. Tmunity Therapeutics — Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse array of diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
A2 Biotherapeutics, Inc. has raised $190.50M while Tmunity Therapeutics has raised $220.00M.
A2 Biotherapeutics, Inc. and Tmunity Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare A2 Biotherapeutics, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at A2 Biotherapeutics, Inc. on 14 Sep 2024, and Tmunity Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes